Caffeine induces behavioural sensitization and overexpression of cocaine-regulated and amphetamine-regulated transcript peptides in mice

Behavioural Pharmacology

Volumn 25, Issue 1, 2014, Pages 32-43

  Hu, Zhenzhen ^a,b   Lee, Chung Il ^b   Han, Jin Yi ^b   Oh, Eun Hye ^b   Ryu, Jong Hoon ^c   Hong, Jin Tae ^b   Kim, Youngsoo ^b   Oh, Ki Wan ^b  

^a NANCHANG UNIVERSITY   (China)

^b Chungbuk National University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

A1 and A2A receptors; behavioural sensitization; caffeine; CART; D1 and D2 receptors; mice striatum; mouse

Indexed keywords

4 [2 [(6 AMINO 9 (N ETHYL BETA DEXTRO RIBOFURANURONAMIDOSYL) 9H PURIN 2 YL)AMINO]ETHYL]BENZENEOPROPANOIC ACID HYDROCHLORIDE; 6 N CYCLOPENTYLADENOSINE; 7 CHLORO 8 HYDROXY 3 METHYL 1 PHENYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPINE HYDROCHLORIDE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CAFFEINE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; MESSENGER RNA; RACLOPRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BEHAVIORAL MEDICINE; BEHAVIORAL SENSITIZATION; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PUTAMEN; REGULATORY MECHANISM; SENSITIZATION;

ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 84891859280     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0000000000000016     Document Type: Article

References (44)

1. Cauli O, Morelli M (2005). Caffeine and the dopaminergic system. Behav Pharmacol 16:63-77. (Pubitemid 40477532)
2. Cheng SV, Pollard JW (1986). c-rasH and ornithine decarboxylase are induced by oestradiol-17 beta in the mouse uterine luminal epithelium independently of the proliferative status of the cell. FEBS Lett 196:309-314. (Pubitemid 16047483)
3. Dallvechia-Adams S, Smith Y, Kuhar MJ (2001). CART peptide-immunoreactive projection from the nucleus accumbens targets substantia nigra pars reticulata neurons in the rat. J Comp Neurol 434:29-39.
4. Dallvechia-Adams S, Kuhar MJ, Smith Y (2002). Cocaine-and amphetamineregulated transcript peptide projections in the ventral midbrain: colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons. J Comp Neurol 448: 360-372. (Pubitemid 34569184)
5. Douglass J, McKinzie AA, Couceyro P (1995). PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15:2471-2481.
6. Evans SM, Critchfield TS, Griffiths RR (1994). Caffeine reinforcement demonstrated in a majority of moderate caffeine users. Behav Pharmacol 5: 231-238. (Pubitemid 24217285)
7. Fekete C, Lechan RM (2006). Neuroendocrine implications for the association between cocaine-and amphetamine-regulated transcript (CART) and hypophysiotropic thyrotropin-releasing hormone (TRH). Peptides 27: 2012-2018. (Pubitemid 44067295)
8. Ferre S, Fuxe K, von Euler G, Johansson B, Fredholm BB (1992). Adenosine-dopamine interactions in the brain. Neuroscience 51:501-512.
9. Ferre S (2010). Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine. J Alzheimers Dis 20 (Suppl 1): S35-S49.
10. Franco R, Ferre S, Agnati L, Torvinen M, Gines S, Hillion J, et al. (2000). Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology 23:S50-S59.
11. Germano CM, de Castro M, Rorato R, Laguna MT, Antunes-Rodrigues J, Elias CF, Elias LL (2007). Time course effects of adrenalectomy and food intake on cocaine-and amphetamine-regulated transcript expression in the hypothalamus. Brain Res 1166:55-64. (Pubitemid 47268304)
12. Hu ZZ, Park KS, Han JY, Jang CG, Oh SK, Kim HC, et al. (2011). Markers in morphine-and cocaine-addicted animals. Biomol Ther 19:45-51.
13. Hubert GW, Kuhar MJ (2006). Colocalization of CART peptide with prodynorphin and dopamine D1 receptors in the rat nucleus accumbens. Neuropeptides 40:409-415. (Pubitemid 44738020)
14. Hubert GW, Manvich DF, Kuhar MJ (2010). Cocaine and amphetamine-regulated transcript-containing neurons in the nucleus accumbens project to the ventral pallidum in the rat and may inhibit cocaine-induced locomotion. Neuroscience 165:179-187.
15. Hunter RG, Jones D, Vicentic A, Hue G, Rye D, Kuhar MJ (2006). Regulation of CART mRNA in the rat nucleus accumbens via D3 dopamine receptors. Neuropharmacology 50:858-864. (Pubitemid 43737003)
16. Jaworski JN, Jones DC (2006). The role of CART in the reward/reinforcing properties of psychostimulants. Peptides 27:1993-2004. (Pubitemid 44067293)
17. Jaworski JN, Kozel MA, Philpot KB, Kuhar MJ (2003). Intra-accumbal injection of CART (cocaine-amphetamine regulated transcript) peptide reduces cocaineinduced locomotor activity. J Pharmacol Exp Ther 307:1038-1044. (Pubitemid 37494223)
18. Jaworski JN, Kimmel HL, Mitrano DA, Tallarida RJ, Kuhar MJ (2007). Intra-VTA CART 55-102 reduces the locomotor effect of systemic cocaine in rats: an isobolographic analysis. Neuropeptides 41:65-72. (Pubitemid 46329100)
19. Jones DC, Kuhar MJ (2006). Cocaine-amphetamine-regulated transcript expression in the rat nucleus accumbens is regulated by adenylyl cyclase and the cyclic adenosine 5'-monophosphate/protein kinase a second messenger system. J Pharmacol Exp Ther 317:454-461.
20. Jones FS, Jing J, Stonehouse AH, Stevens A, Edelman GM (2008). Caffeine stimulates cytochrome oxidase expression and activity in the striatum in a sexually dimorphic manner. Mol Pharmacol 74:673-684.
21. Kaplan GB, Leite-Morris KA, Klufas MA, Fan WY (2009). Intra-VTA adenosine A1 receptor activation blocks morphine stimulation of motor behavior and cortical and limbic Fos immunoreactivity. Eur J Pharmacol 602:268-276.
22. Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova Z, et al. (2003a). Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 28:1281-1291. (Pubitemid 41070898)
23. Karcz-Kubicha M, Quarta D, Hope BT, Antoniou K, Muller CE, Morales M (2003b). Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos. Eur J Neurosci 18:296-302.
24. Karcz-Kubicha M, Ferre S, Diaz-Ruiz O, Quiroz C, Goldberg SR, Hope BT, Morales M (2006). Stimulation of adenosine receptors selectively activates gene expression in striatal enkephalinergic neurons. Neuropsychopharmacology 31:2173-2179. (Pubitemid 44413194)
25. Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, et al. (1997). Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19:103-113. (Pubitemid 27332997)
26. Kilbey MM, Ellinwood EH Jr (1977). Reverse tolerance to stimulant-induced abnormal behavior. Life Sci 20:1063-1075.
27. Kuribara H, Tadokoro S (1989). Reverse tolerance to ambulation-increasing effects of methamphetamine and morphine in 6 mouse strains. Jpn J Pharmacol 49:197-203. (Pubitemid 19064599)
28. Luo Z, Volkow ND, Heintz N, Pan Y, Du C (2011). Acute cocaine induces fast activation of D1 receptor and progressive deactivation of D2 receptor striatal neurons: in vivo optical microprobe [Ca2+]i imaging. J Neurosci 31:13180-13190.
29. Moffett MC, Song J, Kuhar MJ (2011). CART peptide inhibits locomotor activity induced by simultaneous stimulation of D1 and D2 receptors, but not by stimulation of individual dopamine receptors. Synapse 65:1-7.
30. Poleszak E, Malec D (2002). Cocaine-induced hyperactivity is more influenced by adenosine receptor agonists than amphetamine-induced hyperactivity. Pol J Pharmacol 54:359-366.
31. Robinson TE, Becker JB (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157-198. (Pubitemid 16100809)
32. Rogge GA, Jones DC, Green T, Nestler E, Kuhar MJ (2009). Regulation of CART peptide expression by CREB in the rat nucleus accumbens in vivo. Brain Res 1251:42-52.
33. Roh MS, Cui FJ, Ahn YM, Kang UG (2009). Up-regulation of cocaine-and amphetamine-regulated transcript (CART) in the rat nucleus accumbens after repeated electroconvulsive shock. Neurosci Res 65:210-213.
34. Salmi P, Chergui K, Fredholm BB (2005). Adenosine-dopamine interactions revealed in knockout mice. J Mol Neurosci 26:239-244. (Pubitemid 41389416)
35. Schwoch G, Lohmann SM, Walter U, Jung U (1985). Determination of cyclic AMP-dependent protein kinase subunits by an immunoassay reveals a different subcellular distribution of the enzyme in rat parotid than does determination of the enzyme activity. J Cyclic Nucleotide Protein Phosphor Res 10:247-258. (Pubitemid 15033644)
36. Simola N, Cauli O, Morelli M (2006). Sensitization to caffeine and crosssensitization to amphetamine: influence of individual response to caffeine. Behav Brain Res 172:72-79. (Pubitemid 44037812)
37. Singewald N, Salchner P, Sharp T (2003). Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53:275-283. (Pubitemid 36175541)
38. Svenningsson P, Fredholm BB (1997). Caffeine mimics the effect of a dopamine D2/3 receptors agonist on the expression of agonist on the expression of immediate early genes in globus pallidus. Neuropharmacology 36:1309-1317. (Pubitemid 27465619)
39. Svenningsson P, Nergardh R, Fredholm BB (1998). Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat. Neuropharmacology 37:331-337. (Pubitemid 28282638)
40. Svenningsson P, Le Moine C, Fisone G, Fredholm BB (1999). Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol 59:355-396. (Pubitemid 29352341)
41. Tanegashima K, Okamoto S, Nakayama Y, Taya C, Shitara H, Ishii R, et al. (2010). CXCL14 deficiency in mice attenuates obesity and inhibits feeding behavior in a novel environment. PLoS One 5:e10321.
42. Wardle MC, Treadway MT, de Wit H (2012). Caffeine increases psychomotor performance on the effort expenditure for rewards task. Pharmacol Biochem Behav 102:526-531.
43. Zahniser NR, Simosky JK, Mayfield RD, Negri CA, Hanania T, Larson GA, et al. (2000). Functional uncoupling of adenosine A(2A) receptors and reduced response to caffeine in mice lacking dopamine D2 receptors. J Neurosci 20:5949-5957. (Pubitemid 30658386)
44. Zeitlin R, Patel S, Burgess S, Arendash GW, Echeverria V (2011). Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice. Brain Res 1417: 127-136.